BTMD today
$1.09+$0.01 (+0.93%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourExpanding
15 minLeaning Bearish
5 minConsolidating
Daily trend turns up above $1.25
Key levels
Resistance$1.35
Resistance$1.24
Support$1.00
Latest news & SEC filings
EarningsBiote holds Q3 2026 earnings call
GuidanceBiote sees FY2026 revenue above $175 million, below $180.66 million estimate
SEC Filingbiote Corp. filed a report on a major company event (Form 8-K)
All BTMD news →About Biote
Biote trains and certifies medical practitioners in a hormone optimization program, offering education, software tools, and marketing assistance to clinics. It also sells its own branded nutritional supplements. Its customers are clinics and practitioners, mainly in the United States, who treat patients with hormonal imbalances.
Based on the company's 10-K filed Mar 13, 2026.
Nasdaq · Healthcare
biote Corp. (BTMD)
What Is the Price Target for BTMD?
SEPT Low Target
$1.50
SEPT Mid Target
$2.00
SEPT High Target
$4.00
Analyst Consensus
$2.00
Is BTMD a Buy or Sell Right Now?
Thesis
- •Revenue growing -2.5% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BTMD.
Start Free Trial →Is BTMD Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$1.62
14
Moat Score
NONE
6/9
Piotroski Score
2.5
Altman Z-Score
What Is Smart Money Doing with BTMD?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BTMD Growth Story
Revenue YoY
-2.5%
3yr Revenue CAGR
5.2%
EPS Growth YoY
722.22%
FCF Growth YoY
-22.3%
Revenue Trend
STABLE
Dark Pool Trades for BTMD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BTMD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:50:56 | $1.12 | 1,061 | $$1K | BUY |
| 16:49:34 | $1.09 | 3,500 | $$4K | SELL |
| 15:52:25 | $1.10 | 2,000 | $$2K | MIDPOINT |
| 15:18:51 | $1.10 | 1,300 | $$1K | MIDPOINT |
| 17:10:47 | $1.09 | 1,000 | $$1K | BUY |
5 dark pool trades shown · $$10K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for biote Corp. (BTMD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BTMD — frequently asked questions
What is BTMD stock price today?
biote Corp. (BTMD) is at $1.09, up 0.93% (+$0.01) at the Nov 11, 2026 close.
Why is BTMD stock moving today?
Latest BTMD news — Nov 4, 2026: Biote holds Q3 2026 earnings call · Nov 4, 2026: Biote sees FY2026 revenue above $175 million, below $180.66 million estimate
What is the BTMD price target?
The average analyst price target for BTMD is $2.00, ranging from $2 to $4, based on 3 analysts. Latest: B. Riley Securities maintains on Aug 10, 2026.
What do analysts rate BTMD?
Analyst ratings for BTMD: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did BTMD beat earnings?
BTMD last reported on Aug 5, 2026: EPS -$0.23 vs $0.03 expected — a miss of 961.4%.
What is BTMD's P/E ratio?
BTMD trades at a P/E of 11.2 vs a Healthcare average of 17.7.
Does BTMD pay a dividend?
Yes. BTMD's dividend yield is 2.12%.
How much debt does BTMD have?
biote Corp. reported $125M of debt and $11M of cash (Jun 30, 2026).
What are BTMD support and resistance levels?
Support: $1.00. Resistance: $1.24, $1.35, $1.46.
What are insiders doing with BTMD?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on BTMD?
Nov 4, 2026: Biote holds Q3 2026 earnings call · Nov 4, 2026: Biote sees FY2026 revenue above $175 million, below $180.66 million estimate · Nov 4, 2026: biote Corp. filed a report on a major company event (Form 8-K)